# To Evaluate the Impact of Consumption of a Bioactive Compound on Fasting Blood Glucose Levels in Asian Indians With Pre-diabetes

> **NCT06417840** · NA · RECRUITING · sponsor: **Brightseed** · enrollment: 130 (estimated)

## Conditions studied

- PreDiabetes

## Interventions

- **DIETARY_SUPPLEMENT:** N-trans-caffeoyltyramine (NCT) and N-trans-feruloyltyramine (NFT)
- **DIETARY_SUPPLEMENT:** Placebo Control

## Key facts

- **NCT ID:** NCT06417840
- **Lead sponsor:** Brightseed
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-06-22
- **Primary completion:** 2024-10-30
- **Final completion:** 2024-10-30
- **Target enrollment:** 130 (ESTIMATED)
- **Last updated:** 2024-07-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06417840

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06417840, "To Evaluate the Impact of Consumption of a Bioactive Compound on Fasting Blood Glucose Levels in Asian Indians With Pre-diabetes". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06417840. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*